Welcome
We harness our revolutionary Phylomer intracellular delivery and drug discovery technology to develop next generation treatment solutions for life-threatening diseases
Phylomer Libraries
Delivery Into Cells
Drug Discovery
Oncology Pipeline
Phylogica’s disruptive technology is based on a unique drug delivery and discovery engine, creating a new platform for drug development that allows unprecedented access to disease targets beyond the reach of existing therapies
Phylogica is developing next generation intracellular biological therapeutics, including its own preclinical Myc-inhibitor oncology payload, using its proprietary best-in-class cell penetrating Functional Penetrating Phylomer® (FPP) endosome escape technology. Both the payload and delivery modules are derived from Phylogica’s proprietary Phylomer® peptide libraries.
Phylogica offers access to its intracellular delivery technology for diverse protein/nucleic acid payloads. Ongoing and past discovery alliance partners include Roche, Medimmune, Pfizer, Janssen and Genentech.
READ MORE ABOUT OUR ONCOLOGY PIPELINE
Phylogica welcomes new partnerships
Enabling innovation partners to develop their own therapies against their intracellular disease targets of choice.
ACADEMIC PARTNERS INDUSTRY PARTNERS